
Raffaele Giusti/LinkedIn
Mar 28, 2025, 20:11
Raffaele Giusti: MARIPOSA overall survival data at ELCC25
Raffaele Giusti, Medical director at Azienda Ospedaliera Sant’Andrea, shared on X:
“MARIPOSA OS data at ELCC25. While the combination offers a statistically significant OS advantage, the absolute clinical benefit is disappointingly modest.
Should more always mean better? Or should we be striving for smarter, not just stronger, strategies?”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 30, 2025, 23:21
Mar 30, 2025, 18:52
Mar 30, 2025, 18:31
Mar 30, 2025, 18:04